Position history for Capital Research Global Investors's holdings in BIOMARIN PHARMACEUTICAL INC
Capital Research Global Investors holds 3.5M shares of BMRN (BIOMARIN PHARMACEUTICAL INC), worth $197.2M as of 2026-Q1. The position was increased (+37.1% shares). BMRN represents 0.0% of Capital Research Global Investors's portfolio.
Current Value
$197.2M
Current Shares
3.5M
Total Value Change
-$600.8M
Total Shares Change
-6.2M
Other major holders of BMRN: PRIMECAP MANAGEMENT CO/CA/, BlackRock Finance, Inc.
Increased |
| 3.5M |
+37.1% |
| $197.2M |
| 0.0% |
| $58.53 |
40 |
| 2025-Q4 | Increased | 2.5M | +0.4% | $151.4M | 0.0% | $58.99 | 30 |
| 2025-Q3 | Increased | 2.5M | +547.5% | $137.4M | 0.0% | $54.02 | 49 |
| 2025-Q2 | Decreased | 391,879 | -95.7% | $21.5M | 0.0% | $55.17 | 0 |
| 2025-Q1 | Decreased | 9.2M | -29.6% | $646.9M | 0.1% | $71.44 | 0 |
| 2024-Q4 | Increased | 13M | +23.8% | $853.9M | 0.2% | $65.45 | 46 |
| 2024-Q3 | Increased | 10.5M | +8.3% | $737.7M | 0.2% | $70.58 | 41 |
| 2024-Q2 | Increased | 9.7M | +48.6% | $798M | 0.2% | $82.33 | 52 |